Interaction databaseSupplement × PrescriptionReviewed May 2026

Duloxetine and MDMA, contraindicated.

Duloxetine directly interferes with MDMA pharmacology at serotonin and norepinephrine transporters. In a controlled human study, duloxetine reduced MDMA's subjective and physiologic effects, which can encourage unsafe redosing, while MDMA exposure and serotonergic load remain clinically concerning. The combination can raise risk for serotonin syndrome, hyperthermia, hypertension, arrhythmia, and seizures.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Duloxetine and MDMA
Pair type
Contraindicated
Evidence (highest tier)
Moderate
Source citations
3 sources
Stack Score effect
−25 to your Stack Score (per scored contraindication row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Contraindicated · Moderate evidence

Contraindicated

What is happening. Duloxetine directly interferes with MDMA pharmacology at serotonin and norepinephrine transporters. In a controlled human study, duloxetine reduced MDMA's subjective and physiologic effects, which can encourage unsafe redosing, while MDMA exposure and serotonergic load remain clinically concerning. The combination can raise risk for serotonin syndrome, hyperthermia, hypertension, arrhythmia, and seizures.

Mechanism. MDMA depends on SERT and NET to enter monoamine neurons and drive reverse serotonin and norepinephrine transport. Duloxetine inhibits SERT and NET and can inhibit CYP2D6, altering MDMA pharmacodynamics and potentially its exposure.

Recommendation. Do not use MDMA while taking duloxetine. Do not increase MDMA doses to overcome duloxetine-related blunting. Seek emergency care for high fever, severe agitation, confusion, clonus, chest pain, fainting, or severe headache after exposure.

Sources (3)
  1. Hysek CM, Simmler LD, Nicola VG, et al. Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One. 2012;7(5):e36476. PMID 22574166
  2. Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology (Berl). 2022;239(6):1945-1976. PMID 35253070
  3. Makunts T, Jerome L, Abagyan R, de Boer A. Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database. Front Psychiatry. 2021;12:824288. PMID 35140642

Stack Score

How this pair moves the number.

Effect on the composite score

If both Duloxetine and MDMA are in the same stack, this pair applies −25 to your Stack Score (per scored contraindication row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.